Mind Medicine (MindMed) Statistics
Share Statistics
Mind Medicine (MindMed) has 73.33M shares outstanding. The number of shares has increased by 4.02% in one year.
| Shares Outstanding | 73.33M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -9.87% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 70.91M |
| Failed to Deliver (FTD) Shares | 25.74K |
| FTD / Avg. Volume | 1.88% |
Short Selling Information
The latest short interest is 9.44M, so 12.88% of the outstanding shares have been sold short.
| Short Interest | 9.44M |
| Short % of Shares Out | 12.88% |
| Short % of Float | 13.31% |
| Short Ratio (days to cover) | 6.41 |
Valuation Ratios
The PE ratio is -1.5 and the forward PE ratio is -5.98.
| PE Ratio | -1.5 |
| Forward PE | -5.98 |
| PS Ratio | 0 |
| Forward PS | 18.7 |
| PB Ratio | 1.83 |
| P/FCF Ratio | -2.23 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Mind Medicine (MindMed) Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.22 |
| Quick Ratio | 3.22 |
| Debt / Equity | 0.18 |
| Total Debt / Capitalization | 15.31 |
| Cash Flow / Debt | -4.56 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.23% and return on capital (ROIC) is -101.74%.
| Return on Equity (ROE) | -1.23% |
| Return on Assets (ROA) | -0.77% |
| Return on Capital (ROIC) | -101.74% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.68M |
| Employee Count | 57 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 65.45% in the last 52 weeks. The beta is 2.33, so Mind Medicine (MindMed) 's price volatility has been higher than the market average.
| Beta | 2.33 |
| 52-Week Price Change | 65.45% |
| 50-Day Moving Average | 7.35 |
| 200-Day Moving Average | 7.52 |
| Relative Strength Index (RSI) | 41.33 |
| Average Volume (20 Days) | 1.37M |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.16M |
| Operating Income | -93.87M |
| Net Income | -95.73M |
| EBITDA | -92.57M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -2.44 |
Balance Sheet
The company has 99.70M in cash and 14.13M in debt, giving a net cash position of 85.58M.
| Cash & Cash Equivalents | 99.70M |
| Total Debt | 14.13M |
| Net Cash | 85.58M |
| Retained Earnings | -290.20M |
| Total Assets | 319.77M |
| Working Capital | 266.09M |
Cash Flow
In the last 12 months, operating cash flow was -64.36M and capital expenditures 0, giving a free cash flow of -64.36M.
| Operating Cash Flow | -64.36M |
| Capital Expenditures | 0 |
| Free Cash Flow | -64.36M |
| FCF Per Share | -1.64 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -38.3% |
| FCF Yield | -13.79% |
Analyst Forecast
The average price target for MNMD is $20, which is 214% higher than the current price. The consensus rating is "Buy".
| Price Target | $20 |
| Price Target Difference | 214% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
Stock Splits
The last stock split was on Aug 29, 2022. It was a backward split with a ratio of 1:15.
| Last Split Date | Aug 29, 2022 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | 4.1 |
| Piotroski F-Score | 3 |